James D. Marks
Directeur/Membre du Conseil chez Silver Creek Pharmaceuticals, Inc.
Profil
James D.
Marks is the founder of MIGS LLC, which was founded in 2013.
Dr. Marks is also the founder of Hermes Biosciences, Inc. Currently, Dr. Marks is a Director at Silver Creek Pharmaceuticals, Inc.
Postes actifs de James D. Marks
| Sociétés | Poste | Début |
|---|---|---|
Silver Creek Pharmaceuticals, Inc.
 Silver Creek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Silver Creek Pharmaceuticals, Inc. develops novel regenerative medicines. The firm focuses on treating cardiovascular disease. Its molecules are designed to promote resilience and regeneration of damaged tissues after acute or chronic injury. The company was founded in 2010 and is headquartered in San Francisco, CA. | Directeur/Membre du Conseil | - |
Anciens postes connus de James D. Marks
| Sociétés | Poste | Fin |
|---|---|---|
Hermes Biosciences, Inc.
 Hermes Biosciences, Inc. BiotechnologyHealth Technology Hermes Biosciences, Inc. develops innovative targeted drug delivery technologies for therapeutic and other biomedical applications. The company was founded by John W. Park, James D. Marks, Keelung Hong and Christopher Benz and is headquartered in South San Francisco, CA. | Fondateur | - |
MIGS LLC
 MIGS LLC BiotechnologyHealth Technology MIGS LLC specializes in antibody production. It provides synthesis and cloning, purification, production, characterization, high throughput production, antibody humanization, and engineering. The company was founded by Michael Feldhaus, James D. Marks, and Jose Varghese in 2013 and is headquartered in Lebanon, NH. | Fondateur | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
MIGS LLC
MIGS LLC BiotechnologyHealth Technology MIGS LLC specializes in antibody production. It provides synthesis and cloning, purification, production, characterization, high throughput production, antibody humanization, and engineering. The company was founded by Michael Feldhaus, James D. Marks, and Jose Varghese in 2013 and is headquartered in Lebanon, NH. | Health Technology |
Hermes Biosciences, Inc.
Hermes Biosciences, Inc. BiotechnologyHealth Technology Hermes Biosciences, Inc. develops innovative targeted drug delivery technologies for therapeutic and other biomedical applications. The company was founded by John W. Park, James D. Marks, Keelung Hong and Christopher Benz and is headquartered in South San Francisco, CA. | Health Technology |
Silver Creek Pharmaceuticals, Inc.
Silver Creek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Silver Creek Pharmaceuticals, Inc. develops novel regenerative medicines. The firm focuses on treating cardiovascular disease. Its molecules are designed to promote resilience and regeneration of damaged tissues after acute or chronic injury. The company was founded in 2010 and is headquartered in San Francisco, CA. | Health Technology |
